Q2 2023 Financial Statement
SECURITIES AND EXCHANGE COMMISSION
___________________________________________
FORM 10-Q
______________________________________________________________________________________
- Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended
June 30, 2023
or
- Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from
_______ to _______
Commission File Number: 001-15811
_________________________________________
MARKEL GROUP INC.
(Exact name of registrant as specified in its charter)
___________________________________________________________________________________
|
|
54-1959284 |
|
(State or other jurisdiction of |
(I.R.S. Employer |
|
incorporation or organization) |
Identification No.) |
|
|
|
|
(Address of principal executive offices) ( |
(804) 747-0136
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class |
Trading Symbol(s) |
|
||
|
Common Stock, no par value |
MKL |
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer |
x |
Accelerated filer |
☐ |
Non-accelerated filer |
☐ |
|
Smaller reporting company |
☐ |
Emerging growth company |
☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No x
Number of shares of the registrant's common stock outstanding at
|
|
||
|
Form 10-Q |
||
|
Index |
||
|
Page Number |
||
|
Item 1. |
||
|
Consolidated BalanceSheets-June30,2023 and |
||
|
Consolidated Statements of Income (Loss) and Comprehensive Income(Loss)-Quartersand Six Months Ended |
||
|
Consolidated Statements of Changes inEquity-Quartersand Six Months Ended |
||
|
Condensed Consolidated Statements of Cash Flows-Six Months Ended |
7 |
|
|
Notes to Consolidated Financial Statements |
8 |
|
|
Item 2. |
Management's Discussion and Analysis of Financial Condition and Results of Operations |
30 |
|
Item 3. |
Quantitative and Qualitative Disclosures About Market Risk |
50 |
|
Item 4. |
Controls and Procedures |
51 |
|
PART II. OTHER INFORMATION |
||
|
Item 1. |
Legal Proceedings |
51 |
|
Item 2. |
Unregistered Sales of |
52 |
|
Item 5. |
Other Information |
52 |
|
Item 6. |
Exhibits |
53 |
|
Signatures |
55 |
|
|
2 |
||
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
MARKEL GROUP INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
|
|
|
||||
|
2023 |
2022 |
||||
|
(dollars in thousands) |
(unaudited) |
||||
|
ASSETS |
|||||
|
Investments, at estimated fair value: |
|||||
|
Fixed maturity securities, available-for-sale (amortized cost of |
$ |
12,745,692 |
$ |
11,856,835 |
|
|
Equity securities (cost of |
8,688,860 |
7,671,912 |
|||
|
Short-term investments, available-for-sale (estimated fair value approximates cost) |
2,039,061 |
2,669,262 |
|||
|
Total Investments |
23,473,613 |
22,198,009 |
|||
|
Cash and cash equivalents |
4,305,884 |
4,137,432 |
|||
|
Restricted cash and cash equivalents |
935,045 |
1,084,081 |
|||
|
Receivables |
3,695,172 |
2,961,056 |
|||
|
Reinsurance recoverables |
8,296,043 |
8,446,745 |
|||
|
Deferred policy acquisition costs |
1,013,304 |
925,483 |
|||
|
Prepaid reinsurance premiums |
2,486,203 |
2,066,114 |
|||
|
|
2,626,588 |
2,638,838 |
|||
|
Intangible assets |
1,677,621 |
1,747,464 |
|||
|
Other assets |
3,674,660 |
3,586,037 |
|||
|
Total Assets |
$ |
52,184,133 |
$ |
49,791,259 |
|
|
LIABILITIES AND EQUITY |
|||||
|
Unpaid losses and loss adjustment expenses |
$ |
21,374,813 |
$ |
20,947,898 |
|
|
Life and annuity benefits |
643,572 |
650,721 |
|||
|
Unearned premiums |
7,072,182 |
6,220,748 |
|||
|
Payables to insurance and reinsurance companies |
972,194 |
669,742 |
|||
|
Senior long-term debt and other debt (estimated fair value of |
3,813,917 |
4,103,629 |
|||
|
Other liabilities |
3,603,932 |
3,461,482 |
|||
|
Total Liabilities |
37,480,610 |
36,054,220 |
|||
|
Redeemable noncontrolling interests |
464,442 |
523,154 |
|||
|
Commitments and contingencies |
|||||
|
Shareholders' equity: |
|||||
|
Preferred stock |
591,891 |
591,891 |
|||
|
Common stock |
3,515,362 |
3,493,893 |
|||
|
Retained earnings |
10,818,989 |
9,832,804 |
|||
|
Accumulated other comprehensive loss |
(740,743) |
(767,494) |
|||
|
Total Shareholders' Equity |
14,185,499 |
13,151,094 |
|||
|
Noncontrolling interests |
53,582 |
62,791 |
|||
|
Total Equity |
14,239,081 |
13,213,885 |
|||
|
Total Liabilities and Equity |
$ |
52,184,133 |
$ |
49,791,259 |
|
See accompanying notes to consolidated financial statements.
3
MARKEL GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS)
(Unaudited)
|
Quarter Ended |
Six Months Ended |
||||||||||
|
2023 |
2022 |
2023 |
2022 |
||||||||
|
(dollars in thousands, except per share data) |
|||||||||||
|
OPERATING REVENUES |
|||||||||||
|
Earned premiums |
$ |
2,031,143 |
$ |
1,833,104 |
$ |
3,998,847 |
$ |
3,592,874 |
|||
|
Net investment income |
169,693 |
96,795 |
329,028 |
189,099 |
|||||||
|
Net investment gains (losses) |
484,527 |
(1,554,643) |
857,090 |
(1,913,042) |
|||||||
|
Products revenues |
784,882 |
776,959 |
1,362,808 |
1,258,580 |
|||||||
|
Services and other revenues |
672,291 |
639,992 |
1,238,152 |
1,270,932 |
|||||||
|
Total Operating Revenues |
4,142,536 |
1,792,207 |
7,785,925 |
4,398,443 |
|||||||
|
OPERATING EXPENSES |
|||||||||||
|
Losses and loss adjustment expenses |
1,187,876 |
1,058,810 |
2,360,890 |
2,031,182 |
|||||||
|
Underwriting, acquisition and insurance expenses |
697,887 |
609,469 |
1,373,592 |
1,199,834 |
|||||||
|
Products expenses |
651,469 |
697,718 |
1,167,225 |
1,145,537 |
|||||||
|
Services and other expenses |
590,817 |
557,481 |
1,071,436 |
1,147,372 |
|||||||
|
Amortization of intangible assets |
44,423 |
45,523 |
88,822 |
91,572 |
|||||||
|
Total Operating Expenses |
3,172,472 |
2,969,001 |
6,061,965 |
5,615,497 |
|||||||
|
Operating Income (Loss) |
970,064 |
(1,176,794) |
1,723,960 |
(1,217,054) |
|||||||
|
Interest expense |
(47,221) |
(50,050) |
(96,659) |
(99,742) |
|||||||
|
Net foreign exchange gains (losses) |
(14,976) |
105,067 |
(47,904) |
128,071 |
|||||||
|
Income (Loss) Before Income Taxes |
907,867 |
(1,121,777) |
1,579,397 |
(1,188,725) |
|||||||
|
Income tax (expense) benefit |
(191,937) |
238,953 |
(325,668) |
257,089 |
|||||||
|
Net Income (Loss) |
715,930 |
(882,824) |
1,253,729 |
(931,636) |
|||||||
|
Net income attributable to noncontrolling interests |
(20,419) |
(32,972) |
(69,566) |
(35,901) |
|||||||
|
Net Income (Loss) to Shareholders |
695,511 |
(915,796) |
1,184,163 |
(967,537) |
|||||||
|
Preferred stock dividends |
(18,000) |
(18,000) |
(18,000) |
(18,000) |
|||||||
|
Net Income (Loss) to Common Shareholders |
$ |
677,511 |
$ |
(933,796) |
$ |
1,166,163 |
$ |
(985,537) |
|||
|
OTHER COMPREHENSIVE INCOME (LOSS) |
|||||||||||
|
Change in net unrealized gains (losses) on available-for-sale investments, net of |
|||||||||||
|
taxes: |
|||||||||||
|
Net holding gains (losses) arising during the period |
$ |
(134,991) |
$ |
(362,392) |
$ |
26,215 |
$ |
(883,592) |
|||
|
Reclassification adjustments for net losses included in net income (loss) |
405 |
1,261 |
3,399 |
1,698 |
|||||||
|
Change in net unrealized gains (losses) on available-for-sale investments, net |
(134,586) |
(361,131) |
29,614 |
(881,894) |
|||||||
|
of taxes |
|||||||||||
|
Change in discount rate for life and annuity benefits, net of taxes |
3,224 |
63,198 |
(5,828) |
123,891 |
|||||||
|
Change in foreign currency translation adjustments, net of taxes |
361 |
(4,275) |
2,940 |
(5,523) |
|||||||
|
Change in net actuarial pension loss, net of taxes |
18 |
373 |
36 |
1,505 |
|||||||
|
Total Other Comprehensive Income (Loss) |
(130,983) |
(301,835) |
26,762 |
(762,021) |
|||||||
|
Comprehensive Income (Loss) |
584,947 |
(1,184,659) |
1,280,491 |
(1,693,657) |
|||||||
|
Comprehensive income attributable to noncontrolling interests |
(20,398) |
(33,029) |
(69,577) |
(35,945) |
|||||||
|
Comprehensive Income (Loss) to Shareholders |
$ |
564,549 |
$ |
(1,217,688) |
$ |
1,210,914 |
$ |
(1,729,602) |
|||
|
NET INCOME (LOSS) PER COMMON SHARE |
|||||||||||
|
Basic |
$ |
50.20 |
$ |
(69.15) |
$ |
87.50 |
$ |
(75.56) |
|||
|
Diluted |
$ |
50.09 |
$ |
(69.15) |
$ |
87.34 |
$ |
(75.56) |
|||
See accompanying notes to consolidated financial statements.
4
MARKEL GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(Unaudited)
Quarter Ended
|
Accumulated |
Total |
Redeemable |
||||||||||||||||||
|
Preferred |
Common |
Retained |
Other |
Noncontrolling |
||||||||||||||||
|
Comprehensive |
Shareholders' |
Total Equity |
Noncontrolling |
|||||||||||||||||
|
Stock |
Stock |
Earnings |
Loss |
Equity |
Interests |
Interests |
||||||||||||||
|
$ |
591,891 |
$ |
3,506,972 |
|
$ |
(609,781) |
$ |
13,744,483 |
$ |
44,838 |
|
$ |
491,883 |
|
Net income |
695,511 |
- |
695,511 |
8,745 |
704,256 |
11,674 |
|||||||||||||||||
|
Other comprehensive loss |
- |
(130,962) |
(130,962) |
- |
(130,962) |
(21) |
|||||||||||||||||
|
Comprehensive Income |
564,549 |
8,745 |
573,294 |
11,653 |
|||||||||||||||||||
|
Repurchase of common stock |
- |
- |
(105,197) |
- |
(105,197) |
- |
(105,197) |
- |
|||||||||||||||
|
Preferred stock dividends |
- |
- |
(18,000) |
- |
(18,000) |
- |
(18,000) |
- |
|||||||||||||||
|
Restricted stock awards expensed |
- |
4,830 |
- |
- |
4,830 |
- |
4,830 |
- |
|||||||||||||||
|
Adjustment of redeemable noncontrolling |
- |
- |
(5,758) |
- |
(5,758) |
- |
(5,758) |
5,758 |
|||||||||||||||
|
interests |
|||||||||||||||||||||||
|
Purchase of noncontrolling interests |
- |
3,931 |
- |
- |
3,931 |
- |
3,931 |
(36,431) |
|||||||||||||||
|
Other |
- |
(371) |
(2,968) |
- |
(3,339) |
(1) |
(3,340) |
(8,421) |
|||||||||||||||
|
|
$ |
591,891 |
$ |
3,515,362 |
$ |
10,818,989 |
$ |
(740,743) |
$ |
14,185,499 |
$ |
53,582 |
$ |
14,239,081 |
$ |
464,442 |
|||||||
|
Accumulated |
Total |
Redeemable |
|||||||||||||||||||||
|
Preferred |
Common |
Retained |
Other |
Noncontrolling |
|||||||||||||||||||
|
Comprehensive |
Shareholders' |
Noncontrolling |
|||||||||||||||||||||
|
Six Months Ended |
Stock |
Stock |
Earnings |
Loss |
Equity |
Interests |
Total Equity |
Interests |
|||||||||||||||
|
(dollars in thousands) |
|||||||||||||||||||||||
|
|
$ |
591,891 |
$ |
3,493,893 |
$ |
9,832,804 |
$ |
(767,494) |
$ |
13,151,094 |
$ |
62,791 |
$ |
13,213,885 |
$ |
523,154 |
|||||||
|
Net income |
1,184,163 |
- |
1,184,163 |
53,438 |
1,237,601 |
16,128 |
|||||||||||||||||
|
Other comprehensive income |
- |
26,751 |
26,751 |
- |
26,751 |
11 |
|||||||||||||||||
|
Comprehensive Income |
1,210,914 |
53,438 |
1,264,352 |
16,139 |
|||||||||||||||||||
|
Repurchase of common stock |
- |
- |
(187,161) |
- |
(187,161) |
- |
(187,161) |
- |
|||||||||||||||
|
Preferred stock dividends |
- |
- |
(18,000) |
- |
(18,000) |
- |
(18,000) |
- |
|||||||||||||||
|
Restricted stock awards expensed |
- |
26,528 |
- |
- |
26,528 |
- |
26,528 |
- |
|||||||||||||||
|
Adjustment of redeemable noncontrolling |
- |
- |
7,715 |
- |
7,715 |
- |
7,715 |
(7,715) |
|||||||||||||||
|
interests |
|||||||||||||||||||||||
|
Purchase of noncontrolling interests |
- |
(4,688) |
- |
- |
(4,688) |
- |
(4,688) |
(49,477) |
|||||||||||||||
|
Redemption of |
- |
- |
- |
- |
- |
(62,646) |
(62,646) |
- |
|||||||||||||||
|
noncontrolling interests |
|||||||||||||||||||||||
|
Other |
- |
(371) |
(532) |
- |
(903) |
(1) |
(904) |
(17,659) |
|||||||||||||||
|
|
$ |
591,891 |
$ |
3,515,362 |
$ |
10,818,989 |
$ |
(740,743) |
$ |
14,185,499 |
$ |
53,582 |
$ |
14,239,081 |
$ |
464,442 |
|||||||
5
Attachments
Disclaimer


2Q 2023 Financial Supplement
American Financial Group, Inc. Announces Second Quarter Results
Advisor News
- What to discuss during the first retirement planning meeting
- Inflation, competing priorities and uncertainty erode retirement security
- As health premiums rise, 1 in 8 workers cut retirement savings
- CT governor’s candidates claims: What’s true, and what’s misleading
- Retaining clients by giving them a memorable experience
More Advisor NewsAnnuity News
- National Life Group expands annuity portfolio
- AM Best to Join Life/Annuity Insurance-Focused Panel Discussion at Capitol Forum Event
- USAA Earns No. 1 Ranking in JD Power Individual Annuity Study for the Third Consecutive Year
- How flexible annuities fit today’s retirement portfolios
- Foresters Financial appoints Tom Ross as chief distribution officer for U.S. annuity sales
More Annuity NewsHealth/Employee Benefits News
- Kenai renews employee health coverage despite $792K jump in costs
- Healthcare navigator: More people are dropping insurance or choosing higher-deductible plans
- UnitedHealth Group Incorporated Trademark Application for “HPN” Filed: UnitedHealth Group Incorporated
- Studies from American Cancer Society Reveal New Findings on Colon Cancer (Effects of private health insurance coverage gains on colorectal cancer outcomes: a modeling study): Oncology – Colon Cancer
- New Managed Care Findings Has Been Reported by Investigators at Harvard University (Authors’ Reply To the Discussion of ‘balanced and Robust Randomized Treatment Assignments: the Finite Selection Model for the Health Insurance Experiment and …): Managed Care
More Health/Employee Benefits NewsLife Insurance News